Electrical Muscle Stimulation Effect Versus Myofascial Release on Quality of Life in Female Fibromyalgia

Not Applicable

Not yet recruiting

• Conditions: Electric Stimulation; Myofascial Release; Fibromyalgia

• Registration Number: NCT06696651
• Lead Sponsor: Cairo University

Brief Summary

the study was done to investigate the effect of Electrical Muscle Stimulation as muscle strengthening versus the effect of myofascial releasing on quality of life in female fibromyalgia patients while following Mediterranean diet.

Detailed Description

Fibromyalgia is a chronic pain condition characterized by unrefreshing sleep, physical exhaustion, and cognitive difficulties. It affects all populations worldwide and requires a diagnosis of widespread pain for at least three months. People with Fibromyalgia show abnormal endogenous pain modulation, including reduced conditioned pain modulation and exercise-induced hypoalgesia. Exercise is considered a first-line treatment for Fibromyalgia. Electrical myostimulation has been shown to improve pain, sleep subscales, and quality of life. A potential causal link between Fibromyalgia and micronutrient deficiency has been suggested. The study focuses on fibromyalgia, which affects mostly females and is difficult to diagnose easily. Electrical myostimulation and myofascial release are effective treatments for Fibromyalgia.

Study Timeline

• Status Verified: 2024-11
• Study First Submitted: 2024-11-18
• Study First Submitted QC: 2024-11-18
• Last Update Submitted: 2024-11-18
• Study First Posted: 2024-11-20
• Last Update Posted: 2024-11-20
• Study Start: 2024-12-15
• Primary Completion: 2025-02-15
• Study Completion: 2025-03-15

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

1. Sixty females have diagnosed suffering from fibromyalgia syndrome.
2. Their ages will be ranged from 45 to 55 years old.
3. Their body mass index will be ranged from 25 to 34 ( overweight and obese type 1)
4. They have willingness to participate in this study.

Exclusion Criteria

1. Peripheral vascular diseases.
2. Drug abuse.
3. Smokers.
4. Chest disease. ( either obstructive or restrictive ).
5. Clinical signs of sever cardiac events ( eg. Congestive heart disease).

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Assessment of change of body mass index	at baseline and after 6 weeks	to measure body weight and height to calculate BMI for characterizing the sample.
Assessment of change of pressure pain threshold using algometry	at baseline and after 6 weeks	Algometry is a useful tool for assessing central allodynia and hyperalgesia in FM and other pain conditions. It can provide insights into psychological factors influencing pain experience, new dynamic pain indicators, and neuroimaging techniques.

Secondary Outcome Measures

Name	Time	Method
assessment of fibromyalgia using Fibromyalgia Impact Questionnaire	at baseline and after 6 weeks	The FIQ-A measures physical function, work, and well-being, including pain, fatigue, stiffness, anxiety, and depression. The Arabic version has acceptable reliability and validity criteria, suitable for clinical practice and research in the Arabic speaking population.

Trial Locations

Locations (1)

out-patient clinic, new Cairo hospital; 🇪🇬 Cairo, Egypt